RVLP | | RVL Pharmaceuticals plc | Harsaul Foundation | 10% Owner | Oct 19, 2023 | Sale | $0.05 | 9,363,760 | 431,669 | 9,700,000 | Oct 23, 2023, 04:23 PM |
RVLP | | RVL Pharmaceuticals plc | Harsaul Foundation | 10% Owner | Oct 20, 2023 | Sale | $0.03 | 4,758,899 | 148,478 | 4,941,101 | Oct 23, 2023, 04:23 PM |
RVLP | | RVL Pharmaceuticals plc | Altchem Ltd | 10% Owner | Oct 20, 2023 | Sale | $0.03 | 4,758,899 | 148,478 | 4,941,101 | Oct 23, 2023, 01:06 PM |
RVLP | | RVL Pharmaceuticals plc | Altchem Ltd | 10% Owner | Oct 19, 2023 | Sale | $0.05 | 9,363,760 | 431,669 | 9,700,000 | Oct 23, 2023, 01:06 PM |
RVLP | | RVL Pharmaceuticals plc | Harsaul Foundation | 10% Owner | Oct 18, 2023 | Sale | $0.06 | 3,421,537 | 221,031 | 19,063,760 | Oct 20, 2023, 03:59 PM |
RVLP | | RVL Pharmaceuticals plc | Altchem Ltd | 10% Owner | Oct 18, 2023 | Sale | $0.06 | 3,421,537 | 221,031 | 19,063,760 | Oct 20, 2023, 01:36 PM |
RVLP | | RVL Pharmaceuticals plc | Lask Alisa | Director | Aug 10, 2023 | Option Exercise | $0.49 | 12,000 | 5,880 | 112,557 | Aug 14, 2023, 05:35 PM |
RVLP | | RVL Pharmaceuticals plc | Schaub James | EVP and COO | May 18, 2023 | Option Exercise | $0.87 | 5,577 | 4,852 | 524,835 | May 22, 2023, 09:21 PM |
RVLP | | RVL Pharmaceuticals plc | Klein Christopher | General Counsel & Secretary | May 18, 2023 | Option Exercise | $0.87 | 5,447 | 4,739 | 180,573 | May 22, 2023, 09:18 PM |
RVLP | | RVL Pharmaceuticals plc | Klein Christopher | General Counsel & Secretary | Jan 24, 2023 | Option Exercise | $1.26 | 9,608 | 12,106 | 186,020 | Jan 26, 2023, 05:16 PM |
RVLP | | RVL Pharmaceuticals plc | Schaub James | EVP and COO | Jan 24, 2023 | Option Exercise | $1.26 | 9,608 | 12,106 | 530,412 | Jan 26, 2023, 05:15 PM |
RVLP | | RVL Pharmaceuticals plc | Schaub James | EVP and COO | Aug 08, 2022 | Buy | $1.55 | 150,000 | 232,500 | 540,020 | Aug 09, 2022, 05:23 PM |
RVLP | | RVL Pharmaceuticals plc | MARKISON BRIAN A | Chief Executive Officer | Aug 08, 2022 | Buy | $1.55 | 850,000 | 1,317,500 | 2,976,020 | Aug 09, 2022, 05:22 PM |
RVLP | | RVL Pharmaceuticals plc | Burgstahler David F | Director | Aug 08, 2022 | Buy | $1.55 | 8,000,000 | 12,400,000 | 23,730,864 | Aug 09, 2022, 05:21 PM |
RVLP | | RVL Pharmaceuticals plc | Venkataraman Sriram | Director | Aug 08, 2022 | Buy | $1.55 | 8,000,000 | 12,400,000 | 23,730,864 | Aug 09, 2022, 05:19 PM |
RVLP | | RVL Pharmaceuticals plc | Avista Healthcare Partners GP, Ltd. | 10% Owner | Aug 08, 2022 | Buy | $1.55 | 8,000,000 | 12,400,000 | 23,730,864 | Aug 09, 2022, 05:18 PM |
RVLP | | RVL Pharmaceuticals plc | deVries Tina Marie | EVP, Research & Development | May 18, 2022 | Option Exercise | $1.40 | 5,447 | 7,626 | 136,141 | May 20, 2022, 04:28 PM |
RVLP | | RVL Pharmaceuticals plc | Klein Christopher | General Counsel & Secretary | May 18, 2022 | Option Exercise | $1.40 | 6,127 | 8,578 | 195,628 | May 20, 2022, 04:27 PM |
RVLP | | RVL Pharmaceuticals plc | Schaub James | EVP and COO | May 18, 2022 | Option Exercise | $1.40 | 6,273 | 8,782 | 390,020 | May 20, 2022, 04:25 PM |
RVLP | | RVL Pharmaceuticals plc | Einhorn Andrew J. | Chief Financial Officer | Jan 24, 2022 | Option Exercise | $1.13 | 9,607 | 10,856 | 141,473 | Jan 26, 2022, 04:31 PM |
RVLP | | RVL Pharmaceuticals plc | Klein Christopher | General Counsel & Secretary | Jan 24, 2022 | Option Exercise | $1.13 | 9,607 | 10,856 | 201,755 | Jan 26, 2022, 04:31 PM |
RVLP | | RVL Pharmaceuticals plc | deVries Tina Marie | EVP, Research & Development | Jan 24, 2022 | Option Exercise | $1.13 | 9,607 | 10,856 | 141,588 | Jan 26, 2022, 04:31 PM |
RVLP | | RVL Pharmaceuticals plc | Schaub James | EVP and COO | Jan 24, 2022 | Option Exercise | $1.13 | 9,607 | 10,856 | 396,293 | Jan 26, 2022, 04:30 PM |
OSMT | | Osmotica Pharmaceuticals plc | Schaub James | EVP and COO | Dec 16, 2021 | Buy | $1.07 | 93,800 | 100,366 | 405,900 | Dec 20, 2021, 05:03 PM |
OSMT | | Osmotica Pharmaceuticals plc | COWAN GREGORY L | Director | Aug 27, 2021 | Option Exercise | $3.31 | 5,506 | 18,225 | 50,055 | Sep 03, 2021, 04:02 PM |
OSMT | | Osmotica Pharmaceuticals plc | WEISS FRED G | Director | Aug 27, 2021 | Option Exercise | $3.31 | 5,506 | 18,225 | 118,466 | Sep 03, 2021, 04:01 PM |
OSMT | | Osmotica Pharmaceuticals plc | COWAN GREGORY L | Director | Jun 18, 2021 | Option Exercise | $2.89 | 18,584 | 53,708 | 55,561 | Jun 22, 2021, 04:05 PM |
OSMT | | Osmotica Pharmaceuticals plc | Schaub James | EVP and COO | May 18, 2021 | Option Exercise | $3.12 | 6,621 | 20,658 | 312,100 | May 20, 2021, 04:07 PM |
OSMT | | Osmotica Pharmaceuticals plc | Klein Christopher | General Counsel & Secretary | May 18, 2021 | Option Exercise | $3.12 | 6,467 | 20,177 | 211,362 | May 20, 2021, 04:06 PM |
OSMT | | Osmotica Pharmaceuticals plc | Einhorn Andrew J. | Chief Financial Officer | May 18, 2021 | Option Exercise | $3.12 | 6,467 | 20,177 | 151,080 | May 20, 2021, 04:06 PM |
OSMT | | Osmotica Pharmaceuticals plc | deVries Tina Marie | EVP, Research & Development | May 18, 2021 | Option Exercise | $3.12 | 6,467 | 20,177 | 151,195 | May 20, 2021, 04:05 PM |
OSMT | | Osmotica Pharmaceuticals plc | Schaub James | EVP and COO | Jan 24, 2021 | Option Exercise | $4.46 | 9,687 | 43,204 | 318,721 | Jan 26, 2021, 07:03 PM |
OSMT | | Osmotica Pharmaceuticals plc | Klein Christopher | General Counsel & Secretary | Jan 24, 2021 | Option Exercise | $4.46 | 9,605 | 42,838 | 217,829 | Jan 26, 2021, 07:03 PM |
OSMT | | Osmotica Pharmaceuticals plc | Einhorn Andrew J. | Chief Financial Officer | Jan 24, 2021 | Option Exercise | $4.46 | 9,668 | 43,119 | 157,547 | Jan 26, 2021, 07:02 PM |
OSMT | | Osmotica Pharmaceuticals plc | deVries Tina Marie | EVP, Research & Development | Jan 24, 2021 | Option Exercise | $4.46 | 9,597 | 42,803 | 157,662 | Jan 26, 2021, 07:01 PM |
OSMT | | Osmotica Pharmaceuticals plc | WEISS FRED G | Director | Jan 24, 2021 | Option Exercise | $4.46 | 5,505 | 24,552 | 81,368 | Jan 26, 2021, 07:01 PM |
OSMT | | Osmotica Pharmaceuticals plc | COWAN GREGORY L | Director | Jan 24, 2021 | Option Exercise | $4.46 | 5,505 | 24,552 | 74,145 | Jan 26, 2021, 07:00 PM |
OSMT | | Osmotica Pharmaceuticals plc | COWAN GREGORY L | Director | May 21, 2020 | Option Exercise | $4.60 | 11,112 | 51,115 | 79,650 | May 22, 2020, 04:27 PM |
OSMT | | Osmotica Pharmaceuticals plc | WEISS FRED G | Director | May 21, 2020 | Option Exercise | $4.60 | 17,778 | 81,779 | 86,873 | May 22, 2020, 04:27 PM |
OSMT | | Osmotica Pharmaceuticals plc | COWAN GREGORY L | Director | Jan 28, 2020 | Option Exercise | $7.00 | 5,505 | 38,535 | 52,046 | Jan 30, 2020, 05:39 PM |
OSMT | | Osmotica Pharmaceuticals plc | Schaub James | EVP and COO | Jan 28, 2020 | Option Exercise | $7.00 | 9,197 | 64,379 | 255,155 | Jan 30, 2020, 05:39 PM |
OSMT | | Osmotica Pharmaceuticals plc | Klein Christopher | General Counsel & Secretary | Jan 28, 2020 | Option Exercise | $7.00 | 9,148 | 64,036 | 155,884 | Jan 30, 2020, 05:39 PM |
OSMT | | Osmotica Pharmaceuticals plc | Einhorn Andrew J. | Chief Financial Officer | Jan 28, 2020 | Option Exercise | $7.00 | 9,184 | 64,288 | 95,665 | Jan 30, 2020, 05:38 PM |
OSMT | | Osmotica Pharmaceuticals plc | WEISS FRED G | Director | Jan 28, 2020 | Option Exercise | $7.00 | 5,505 | 38,535 | 65,935 | Jan 30, 2020, 05:38 PM |
OSMT | | Osmotica Pharmaceuticals plc | deVries Tina Marie | EVP, Research & Development | Jan 28, 2020 | Option Exercise | $7.00 | 9,140 | 63,980 | 95,709 | Jan 30, 2020, 05:38 PM |
OSMT | | Osmotica Pharmaceuticals plc | Harsaul Foundation | 10% Owner | Jan 13, 2020 | Buy | $5.00 | 1,250,000 | 6,250,000 | 22,485,297 | Jan 15, 2020, 04:54 PM |
OSMT | | Osmotica Pharmaceuticals plc | Orbit Co-Invest A-1 LLC | 10% Owner | Jan 13, 2020 | Buy | $5.00 | 1,250,000 | 6,250,000 | 22,485,297 | Jan 15, 2020, 04:39 PM |
OSMT | | Osmotica Pharmaceuticals plc | Venkataraman Sriram | Director | Jan 13, 2020 | Buy | $5.00 | 1,250,000 | 6,250,000 | 15,730,864 | Jan 15, 2020, 04:13 PM |
OSMT | | Osmotica Pharmaceuticals plc | Burgstahler David F | Director | Jan 13, 2020 | Buy | $5.00 | 1,250,000 | 6,250,000 | 15,730,864 | Jan 15, 2020, 04:11 PM |
OSMT | | Osmotica Pharmaceuticals plc | Orbit Co-Invest III LLC | 10% Owner | Jan 13, 2020 | Buy | $5.00 | 1,250,000 | 6,250,000 | 15,730,864 | Jan 15, 2020, 04:11 PM |